Back to Trades
Total Value
$7.8M
Net $5.3M sold
Filing Date
Jul 9, 2026
12 transactions
Sales
$5.3M
12 transactions
Trade Summary
On Jul 8, 2026, ROTHBLATT MARTINE A, Insider, sold $7.8M of UNITED THERAPEUTICS Corp (UTHR) across 12 transactions. The filing covers Common Stock and reflects net selling of $5.3M. Reported prices ranged from $135.42 to $560.79. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- UNITED THERAPEUTICS Corp
- Ticker Symbol
- UTHR
- CIK
- 0001082554
Insider Information
- Role
- Insider
- Location
- SILVER SPRING, MD
Filing Details
- Filing Date
- Jul 9, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0001106578-26-000094
- Form Type
- 4
- Net Trading Amount
- -$5.3M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | 9,500 | $135.42 | Exercise | $1.3M |
| Jul 8, 2026 | Common Stock | 637 | $548.62 | Sale | $349.5K |
| Jul 8, 2026 | Common Stock | 923 | $549.52 | Sale | $507.2K |
| Jul 8, 2026 | Common Stock | 785 | $550.45 | Sale | $432.1K |
| Jul 8, 2026 | Common Stock | 925 | $551.56 | Sale | $510.2K |
| Jul 8, 2026 | Common Stock | 1,490 | $552.51 | Sale | $823.2K |
| Jul 8, 2026 | Common Stock | 1,710 | $553.42 | Sale | $946.4K |
| Jul 8, 2026 | Common Stock | 1,118 | $554.45 | Sale | $619.9K |
| Jul 8, 2026 | Common Stock | 291 | $555.75 | Sale | $161.7K |
| Jul 8, 2026 | Common Stock | 379 | $556.64 | Sale | $211.0K |
| Jul 8, 2026 | Common Stock | 702 | $557.82 | Sale | $391.6K |
| Jul 8, 2026 | Common Stock | 220 | $558.78 | Sale | $122.9K |
| Jul 8, 2026 | Common Stock | 320 | $560.79 | Sale | $179.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | UTHR derivative | 9,500 | $135.42 | Exercise | $1.3M |
Want live alerts when ROTHBLATT MARTINE A trades again?
Download Insider Trades to track UTHR, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- (F10)This transaction was executed in multiple trades at prices ranging from $556.29 to $557.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F11)This transaction was executed in multiple trades at prices ranging from $557.40 to $558.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F12)This transaction was executed in multiple trades at prices ranging from $558.49 to $559.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F13)This transaction was executed in multiple trades at prices ranging from $560.58 to $560.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F14)Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- (F15)Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- (F16)Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- (F17)Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- (F18)Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- (F2)This transaction was executed in multiple trades at prices ranging from $547.98 to $548.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F3)This transaction was executed in multiple trades at prices ranging from $549.00 to $549.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F4)This transaction was executed in multiple trades at prices ranging from $550.00 to $550.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F5)This transaction was executed in multiple trades at prices ranging from $551.00 to $551.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F6)This transaction was executed in multiple trades at prices ranging from $552.07 to $553.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F7)This transaction was executed in multiple trades at prices ranging from $553.08 to $554.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F8)This transaction was executed in multiple trades at prices ranging from $554.11 to $555.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F9)This transaction was executed in multiple trades at prices ranging from $555.22 to $556.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.